3
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1576 |
Iopamidol
SQ-13396,Niopam,Iopamiron,Iopamiro,碘帕醇,B-15000,Isovue |
Others | Others |
Iopamidol (SQ-13396) 是一种 benzenedicarboxamide 化合物。它具有放射性不透明介质、环境污染物和异种生物的作用。 | |||
T32186 |
Ioxynil
BRN 2364041,CA 69-15,Trevespan,Bantrol,Iotox |
||
Ioxynil 是一种腈,它是在4号位置被羟基取代,在3号和5号位置被碘基取代。它的作用是作为一种外来生物,一种环境污染物和除草剂。 | |||
T71305 |
Clofibric Acid-d4
|
||
Clofibric acid-d4 is intended for use as an internal standard for the quantification of clofibric acid by GC- or LC-MS. Clofibric acid is a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 50 µM in a transactivation assay) and the active metabolite of clofibrate. It is formed from clofibrate by tissue and serum esterases. Dietary administration of clofibric acid (0.067-0.22%) reduces serum cholesterol, phospholipid, and triglyceride levels in rats. It decreases glutamate oxal... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8068 |
o-Toluic acid
|
Others | Others |
O-toluic acid 是一种在 2 号位被甲基取代的苯甲酸,可用作一种外源性的代谢物。 | |||
T8093 |
2-Benzylsuccinic acid
2-苄基丁二酸,DL-Benzylsuccinic acid |
Carboxypeptidase | Proteases/Proteasome |
2-Benzylsuccinic acid (DL-Benzylsuccinic acid) 是羧肽酶 A (CPA) 抑制剂。 | |||
T5603 |
Phthalic acid
邻苯二甲酸,1,2-Benzenedioic acid |
Others | Others |
Phthalic acid (1,2-Benzenedioic acid) 是一种邻苯二甲酸酯 (PAE) 的最终常见代谢形式。它可用于合成试剂,如间苯二甲酸 (IPA) 和对苯二甲酸 (TPA)。它广泛的用于邻苯二甲酸酯增塑剂的制备。 | |||
T5554 |
1,3,5-Trimethoxybenzene
Phloroglucinol trimethyl ether,Sym-trimethoxybenzene,1,3,5-三甲氧基苯 |
Others | Others |
1,3,5-Trimethoxybenzene (Phloroglucinol trimethyl ether) 是一种中国玫瑰品种中的主要芳香化合物。它在三个连续的甲基化步骤中由间苯三酚(初始前体) 合成。它能够用于缓解紧张等。 | |||
TJO2758 |
D-Glucuronic acid
D-葡萄糖醛酸,Aldehydo-D-Glucuronic Acid |
Others; Endogenous Metabolite | Metabolism; Others |
D-Glucuronic acid (Aldehydo-D-Glucuronic Acid) 是一种从许多树胶中分离出的重要中间体。它对皮肤具有抗炎作用。它及其衍生物葡萄糖醛酸内酯作为预防人类健康的肝脏解毒剂。 | |||
T40634 |
Perilla ketone
|
||
Perilla ketone is a naturally occurring xenobiotic compound that undergoes activation by pulmonary P450 cytochrome enzymes within the lung. This activation leads to the manifestation of severe pulmonary damage and the development of diffuse pulmonary edema. |